Total revenue of $6.3M in 1QFY23 BioXp® franchise revenue increased by 28% SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and
Telesis Bio Reports First Quarter 2023 Financial Results finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
Total revenue of $6.3M in 1QFY23 BioXp® franchise revenue increased by 28% SAN DIEGO, May 11, 2023 Telesis Bio Inc. , a leader in automated multi-omic and synthetic biology. | June 15, 2023
01.06.2022 - BioXp system and RapidAMP cell-free DNA kit rapidly accelerate antibody discovery pipelines by addressing critical bottlenecks associated with lead candidate gene synthesis, cloning, and scale-up SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) - Codex .